Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Vir Biotechnology, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 10.45 · gapped above the open, then crossed back over prior close. High/low 10.79 at 4:00 am ET, 10.26 at 10:00 am ET.
237 institutional managers report a position in Vir Biotechnology, Inc. worth $1.5B between them, filed on form 13F for the quarter ending 2026-06-30. 25 of them hold 80% of it, the largest being BlackRock, Inc. at 14.05%.
212 more managers in the register
25 managers hold 80% of the $1.5B institutional base. The other 212 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
VIR (Vir Biotechnology, Inc.) has 4 disclosed suppliers and 5 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: XNCR +0.42%, in healthcare.
via Arch Venture Corp, Glaxosmithkline PLC, Qube Research & Technologies Ltd · 8.63% of VIR, 26.89% of LYEL
via Arch Venture Corp, ADAR1 Capital Management, LLC, Ensign Peak Advisors, Inc +1 more · 8.63% of VIR, 17.61% of BOLD
via SB Investment Advisers (uk) Ltd, Point72 Asset Management, L.P. · 7.44% of VIR, 20.90% of CPNG
via Arch Venture Corp, Sio Capital Management, LLC, Algert Global LLC +2 more · 8.63% of VIR, 7.27% of RAPP
via Arch Venture Corp, Principal Financial Group Inc · 8.63% of VIR, 16.79% of SPTX
via SB Investment Advisers (uk) Ltd, Pictet Asset Management Holding SA, Panagora Asset Management Inc · 7.44% of VIR, 11.17% of RLAY
Managers holding a meaningful stake in VIR also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.